Do we more often opt for conservative management of ovarian tumors after changing the Dutch national guideline on enlarged ovaries? A nationwide cohort study
Authors:
Open Access
- 29 July 2024
- journal article
- research article
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 103 (11) , 2183-2192
Abstract
Introduction: Increasing evidence shows that conservative management of ovarian tumors classified as benign, based on ultrasound assessment, is safe. Therefore, conservative management has been adopted as the preferred strategy for certain ovarian tumors assessed as benign in the Dutch national guideline on enlarged ovaries in 2013. The aim of this study was to examine whether implementation of this guideline has led to changes in the number of women/100 000 women undergoing surgery for an ovarian tumor in the Netherlands.Material and Methods: Histopathology reports were requested for all examinations of ovarian and fallopian tube specimens (including cyst enucleations) registered in Palga, the Dutch nationwide pathology databank, from 2011 (before guideline adaptation) and 2019 (after guideline adaptation). Reports on prophylactically removed adnexa, removal for other primary tumors (eg endometrial carcinoma), and for patients under 18 years of age, were excluded from the analysis. Interobserver agreement for the inclusion and classification of reports was assessed using Cohen's Kappa analysis.Results: A total of 34 932 reports were retrieved, 13 917 of which were included in the analysis. In 2011 and 2019, respectively, 96.3/100 000 vs 68.8/100 000 women aged ≥18 underwent surgery for benign ovarian tumors, and 19.6/100 000 vs 18.3/100 000 for borderline and malignant tumors combined. The number of women/100 000 who had surgery for a benign ovarian tumor per 100 000 women declined by 28.5% (p < 0.001) between 2011 and 2019. The largest difference between 2011 and 2019 was observed in the number of women per 100 000 women who underwent surgery for a serous cystadenoma (−40.7%; 20.8/100 000 vs. 12.3/100 000), followed by endometrioma (−33.2%; 14.7/100 000 vs. 9.8/100 000), simple epithelial cyst (−57.3%; 8.4/100 000 vs. 3.6/100 000), and corpus luteum cyst (−57.0%; 4.0/100 000 vs. 1.7/100 000). Cohen's Kappa for the interobserver agreement was 0.96.Conclusions: The number of women/100 000 undergoing surgery for a benign ovarian tumor has substantially decreased in the Netherlands when comparing data before and after implementation of the national guideline in 2013, while the number of women/100 000 undergoing surgery for a malignant or borderline tumor remained the same. These findings suggest successful implementation of the updated guideline, and a measurable effect on increased adoption of conservative management for benign‐looking ovarian tumors.Keywords
Funding Information
- ZonMw (852002128)
- KWF Kankerbestrijding (12694)
This publication has 26 references indexed in Scilit:
- Current uptake and barriers to wider use of the International Ovarian Tumor Analysis (IOTA) models in Dutch gynaecological practiceEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2023
- Ovarian cancer today and tomorrow: A global assessment by world region and Human Development Index using GLOBOCAN 2020International Journal of Cancer, 2022
- Ovarian cancer prognosis in women with endometriosis: a retrospective nationwide cohort study of 32,419 womenAmerican Journal of Obstetrics and Gynecology, 2021
- Expectant management of adnexal masses in selected premenopausal women: a prospective observational studyUltrasound in Obstetrics & Gynecology, 2013
- Prediction of benignity of solid adnexal massesArchives of Gynecology and Obstetrics, 2011
- Effect of Screening on Ovarian Cancer MortalityJAMA, 2011
- Expectant management of ultrasonically diagnosed ovarian dermoid cysts: is it possible to predict outcome?Ultrasound in Obstetrics & Gynecology, 2010
- Natural history of sonographically detected simple unilocular adnexal cysts in asymptomatic postmenopausal womenGynecologic Oncology, 2004
- Cancer incidence in the Netherlands in 1989 and 1990: First results of the nationwide Netherlands cancer registryEuropean Journal of Cancer, 1995
- Sample Size Determinations for the Two Rater Kappa StatisticPsychometrika, 1988